Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for fetal growth restriction
IRCT20140317017034N8Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pentoxifylline in intrauterine growth restriction (IUGR) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Change in TNF-alpha level, Change in sFlt-1 level and 1 more. Started Aug 2019; status: completed.
02
Drugs
pentoxifylline
03
Conditions
intrauterine growth restriction (IUGR)
Beyond the preview
Go deeper on IRCT20140317017034N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140317017034N8.